IT8449063A0 - COMPOSITION OF COMBINED FATTY ACIDS TO LOWER CHOLESTEROL AND TRIGLYCERIDE LEVELS IN THE BLOOD AND METHOD FOR SEPARATING SAID FATTY ACIDS FROM THEIR SOURCES - Google Patents

COMPOSITION OF COMBINED FATTY ACIDS TO LOWER CHOLESTEROL AND TRIGLYCERIDE LEVELS IN THE BLOOD AND METHOD FOR SEPARATING SAID FATTY ACIDS FROM THEIR SOURCES

Info

Publication number
IT8449063A0
IT8449063A0 IT8449063A IT4906384A IT8449063A0 IT 8449063 A0 IT8449063 A0 IT 8449063A0 IT 8449063 A IT8449063 A IT 8449063A IT 4906384 A IT4906384 A IT 4906384A IT 8449063 A0 IT8449063 A0 IT 8449063A0
Authority
IT
Italy
Prior art keywords
fatty acids
blood
sources
separating
composition
Prior art date
Application number
IT8449063A
Other languages
Italian (it)
Other versions
IT1178170B (en
IT8449063A1 (en
Inventor
Rubin David
Original Assignee
Century Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/545,349 external-priority patent/US4526902A/en
Application filed by Century Lab Inc filed Critical Century Lab Inc
Publication of IT8449063A0 publication Critical patent/IT8449063A0/en
Publication of IT8449063A1 publication Critical patent/IT8449063A1/en
Application granted granted Critical
Publication of IT1178170B publication Critical patent/IT1178170B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
    • C11C1/00—Preparation of fatty acids from fats, fatty oils, or waxes; Refining the fatty acids
    • C11C1/02—Preparation of fatty acids from fats, fatty oils, or waxes; Refining the fatty acids from fats or fatty oils
    • C11C1/025—Preparation of fatty acids from fats, fatty oils, or waxes; Refining the fatty acids from fats or fatty oils by saponification and release of fatty acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/005—Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
    • A23D7/0056—Spread compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42—Separation; Purification; Stabilisation; Use of additives
    • C07C51/487—Separation; Purification; Stabilisation; Use of additives by treatment giving rise to chemical modification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/03—Monocarboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
    • C11C1/00—Preparation of fatty acids from fats, fatty oils, or waxes; Refining the fatty acids
    • C11C1/005—Splitting up mixtures of fatty acids into their constituents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Edible Oils And Fats (AREA)
IT49063/84A 1983-10-24 1984-10-24 COMPOSITION OF COMBINED FATTY ACIDS TO LOWER LEVELS OF COLLESTEROL AND TRIGLYCERIDES IN THE BLOOD AND METHOD TO SEPARATE THOSE FATTY ACIDS FROM THEIR SOURCES IT1178170B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54535083A 1983-10-24 1983-10-24
US06/545,349 US4526902A (en) 1983-10-24 1983-10-24 Combined fatty acid composition for treatment or prophylaxis of thrombo-embolic conditions

Publications (3)

Publication Number Publication Date
IT8449063A0 true IT8449063A0 (en) 1984-10-24
IT8449063A1 IT8449063A1 (en) 1986-04-24
IT1178170B IT1178170B (en) 1987-09-09

Family

ID=27067902

Family Applications (1)

Application Number Title Priority Date Filing Date
IT49063/84A IT1178170B (en) 1983-10-24 1984-10-24 COMPOSITION OF COMBINED FATTY ACIDS TO LOWER LEVELS OF COLLESTEROL AND TRIGLYCERIDES IN THE BLOOD AND METHOD TO SEPARATE THOSE FATTY ACIDS FROM THEIR SOURCES

Country Status (7)

Country Link
CA (1) CA1239587A (en)
CH (1) CH661209A5 (en)
DE (1) DE3438630A1 (en)
FR (1) FR2553662B1 (en)
GB (1) GB2148713B (en)
IT (1) IT1178170B (en)
SE (1) SE462701B (en)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8507058D0 (en) * 1985-03-19 1985-04-24 Efamol Ltd Pharmaceutical & dietary compositions
US4792418A (en) * 1985-08-14 1988-12-20 Century Laboratories, Inc. Method of extraction and purification of polyunsaturated fatty acids from natural sources
GB8601915D0 (en) * 1986-01-27 1986-03-05 Efamol Ltd Pharmaceutical compositions
DE3603000A1 (en) * 1986-01-31 1987-08-06 Milupa Ag NEW FATTY MIXTURE OF POLYENIC ACID AND THEIR USE IN THE PRODUCTION OF INFANT FOODS
DE3615710A1 (en) * 1986-05-09 1987-11-26 Hoechst Ag PREPARATIONS FOR THE SYNTHESIS OF PROSTAGLANDINES AND HYDROXY FATTY ACIDS IN BIOLOGICAL SYSTEMS
HU204199B (en) * 1987-03-18 1991-12-30 Caola Kozmetikai Process for producing pharmaceutical compositions containing unsaturated fatty acids and selenium as active components
GB8715914D0 (en) * 1987-07-07 1987-08-12 Efamol Ltd Treatment of cerabral disorders
US4843095A (en) * 1987-08-07 1989-06-27 Century Laboratories, Inc. Free fatty acids for treatment or propyhlaxis of rheumatoid arthritis arthritis
FR2623692B1 (en) * 1987-11-30 1991-05-03 Vernin Jean Gilles NEW DIETETIC OIL
HU210122B (en) * 1988-03-23 1995-02-28 Biorex Kutato Fejlesztoe Kft Process for production of composition against thromboembolytic conditions of circulating system and heart
GB8813766D0 (en) * 1988-06-10 1988-07-13 Efamol Holdings Essential fatty acid compositions
GB8819110D0 (en) * 1988-08-11 1988-09-14 Norsk Hydro As Antihypertensive drug & method for production
US5116871A (en) * 1988-09-13 1992-05-26 Efamol Holdings Plc Fatty acid therapy and compositions for the treatment of myalgic encephalomyelitis
DK162621C (en) * 1989-04-27 1992-04-13 Jon Katborg FOOD FAT PRODUCT AND PROCEDURE FOR PRODUCING THE SAME
DE3924607A1 (en) * 1989-07-21 1991-01-24 Singer Peter Dr Sc Med Diet food contg. omega-3-fatty acid, omega-6-fatty acid - with sodium ions and potassium ions, reducing risk of heart and circulation disease
DE19503993A1 (en) * 1995-02-08 1996-08-14 Johann Friedrich Dr Med Desaga Enteral product contg n-3-fatty acid or deriv and medium chain length tri:glyceride
AU6252196A (en) * 1995-06-07 1996-12-30 Martek Biosciences Corporation Methods for controlling highly unsaturated fatty acid content in various tissues
KR100657642B1 (en) 1996-10-11 2006-12-19 스카리스타 리미티드 Oil comprising eicosapentaenoic acid and/or stearidonic acid
GB9901809D0 (en) 1999-01-27 1999-03-17 Scarista Limited Highly purified ethgyl epa and other epa derivatives for psychiatric and neurological disorderes
DE19903095C2 (en) * 1999-01-27 2003-05-22 Nutrinova Gmbh Obtaining gamma-linolenic acid from protozoa of the genus Colpidium
SE0202188D0 (en) 2002-07-11 2002-07-11 Pronova Biocare As A process for decreasing environmental pollutants in an oil or a fat, a volatile fat or oil environmental pollutants decreasing working fluid, a health supplement, and an animal feed product
EP2295529B2 (en) 2002-07-11 2022-05-18 Basf As Use of a volatile environmental pollutants-decreasing working fluid for decreasing the amount of pollutants in a fat for alimentary or cosmetic use
US6846942B2 (en) 2003-05-20 2005-01-25 David Rubin Method for preparing pure EPA and pure DHA
ITMI20040069A1 (en) 2004-01-21 2004-04-21 Tiberio Bruzzese USE OF HIGH CONCENTRATION N-3 FATTY ACID COMPOSITIONS FOR THE TREATMENT OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM
ES2281270B1 (en) 2005-11-30 2008-07-01 La Morella Nuts, S.A. FUNCTIONAL FOOD WITH POSITIVE EFFECTS IN THE PREVENTION OF CARDIOVASCULAR DISEASES.
US20110236476A1 (en) 2008-09-02 2011-09-29 Amarin Corporation Plc. Pharmaceutical composition comprising eicosapentaenoic acid and nicotinic acid and methods of using same
KR20140007973A (en) 2009-02-10 2014-01-20 아마린 파마, 인크. Methods of treating hypertriglyceridemia
NZ627238A (en) 2009-04-29 2016-02-26 Amarin Pharmaceuticals Ie Ltd Stable pharmaceutical composition comprising ethyl eicosapentaenoate
NZ624963A (en) 2009-04-29 2016-07-29 Amarin Pharmaceuticals Ie Ltd Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
MY172372A (en) 2009-06-15 2019-11-21 Amarin Pharmaceuticals Ie Ltd Compositions and methods for lowering triglycerides
WO2011018096A1 (en) * 2009-08-10 2011-02-17 K.D. Pharma Bexbach Gmbh Phytanic acid fractionation process, fatty acid products and use thereof
WO2011038122A1 (en) 2009-09-23 2011-03-31 Amarin Corporation Plc Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same
NZ744990A (en) 2010-11-29 2019-10-25 Amarin Pharmaceuticals Ie Ltd Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
US11712429B2 (en) 2010-11-29 2023-08-01 Amarin Pharmaceuticals Ireland Limited Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
US11291643B2 (en) 2011-11-07 2022-04-05 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
US20130131170A1 (en) 2011-11-07 2013-05-23 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
EP2800469B1 (en) 2012-01-06 2021-08-25 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering levels of high-sensitivity (hs-crp) in a subject
EP2866801A4 (en) 2012-06-29 2016-02-10 Amarin Pharmaceuticals Ie Ltd Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
WO2014074552A2 (en) 2012-11-06 2014-05-15 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
US9814733B2 (en) 2012-12-31 2017-11-14 A,arin Pharmaceuticals Ireland Limited Compositions comprising EPA and obeticholic acid and methods of use thereof
US20140187633A1 (en) 2012-12-31 2014-07-03 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
US9452151B2 (en) 2013-02-06 2016-09-27 Amarin Pharmaceuticals Ireland Limited Methods of reducing apolipoprotein C-III
US9624492B2 (en) 2013-02-13 2017-04-18 Amarin Pharmaceuticals Ireland Limited Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
US9662307B2 (en) 2013-02-19 2017-05-30 The Regents Of The University Of Colorado Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof
US9283201B2 (en) 2013-03-14 2016-03-15 Amarin Pharmaceuticals Ireland Limited Compositions and methods for treating or preventing obesity in a subject in need thereof
US20140271841A1 (en) 2013-03-15 2014-09-18 Amarin Pharmaceuticals Ireland Limited Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin
US10966968B2 (en) 2013-06-06 2021-04-06 Amarin Pharmaceuticals Ireland Limited Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
US20150065572A1 (en) 2013-09-04 2015-03-05 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing prostate cancer
US9585859B2 (en) 2013-10-10 2017-03-07 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
US10561631B2 (en) 2014-06-11 2020-02-18 Amarin Pharmaceuticals Ireland Limited Methods of reducing RLP-C
WO2015195662A1 (en) 2014-06-16 2015-12-23 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense ldl or membrane polyunsaturated fatty acids
US10406130B2 (en) 2016-03-15 2019-09-10 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
WO2018213663A1 (en) 2017-05-19 2018-11-22 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject having reduced kidney function
US11058661B2 (en) 2018-03-02 2021-07-13 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L
KR102296068B1 (en) 2018-09-24 2021-09-02 애머린 파마슈티칼스 아일랜드 리미티드 Methods of Reducing the Risk of a Cardiovascular Event in a Subject

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1476624A (en) * 1973-05-30 1977-06-16 Cepbepe Tranquiliser medicaments
GB2033745B (en) * 1978-05-26 1983-08-17 Wellcome Found Fatty acid and derivatives thereof for use in treatment or prophylaxis of thromboembolic conditions
AU527784B2 (en) * 1978-05-26 1983-03-24 Bang, Hans Olaf Dr. Treatment of thromboembolic conditions withall-z)-5, 8, 11, 14, 17-eicosapentaenoic acid
GB1604554A (en) * 1978-05-26 1981-12-09 Dyerberg J Pharmaceutical and food formulations
DE3152174A1 (en) * 1980-06-27 1982-08-12 Nippon Oils & Fats Co Ltd THROMBOSIS-PROPHYLATIC AND CURING AGENT
US4377526A (en) * 1981-05-15 1983-03-22 Nippon Suisan Kaisha, Ltd. Method of purifying eicosapentaenoic acid and its esters
GB8302708D0 (en) * 1983-02-01 1983-03-02 Efamol Ltd Pharmaceutical and dietary composition
FR2548021B1 (en) * 1983-06-29 1986-02-28 Dick P R PROLONGED AND CONTINUOUS DERMAL PHARMACEUTICAL COMPOSITIONS BASED ON ESSENTIAL FATTY ACIDS
GB8319073D0 (en) * 1983-07-14 1983-08-17 Efamol Ltd Fatty acid compositions

Also Published As

Publication number Publication date
IT1178170B (en) 1987-09-09
DE3438630A1 (en) 1985-05-02
GB8426765D0 (en) 1984-11-28
GB2148713A (en) 1985-06-05
CH661209A5 (en) 1987-07-15
FR2553662A1 (en) 1985-04-26
FR2553662B1 (en) 1989-06-09
SE8405308L (en) 1985-04-25
SE8405308D0 (en) 1984-10-24
SE462701B (en) 1990-08-20
IT8449063A1 (en) 1986-04-24
GB2148713B (en) 1987-04-23
CA1239587A (en) 1988-07-26

Similar Documents

Publication Publication Date Title
IT8449063A0 (en) COMPOSITION OF COMBINED FATTY ACIDS TO LOWER CHOLESTEROL AND TRIGLYCERIDE LEVELS IN THE BLOOD AND METHOD FOR SEPARATING SAID FATTY ACIDS FROM THEIR SOURCES
ATA118879A (en) METHOD FOR PRODUCING DERIVATIVES FROM NEW DEHYDROCYCLIC IMINOSAURS AND THEIR ESTERS
DE3672270D1 (en) METHOD FOR PRODUCING FATTY ACID ESTERS.
IT8720700A0 (en) PROCEDURE FOR THE EXTRACTION OF ESTERS OF POLYUNSATURATED FATTY ACIDS FROM FISH OILS AND PHARMACEUTICAL AND// DIETARY COMPOSITIONS CONTAINING SAID ESTERS.
GB8413115D0 (en) Fatty acid esters/oils
DE69501677D1 (en) Process for the production of branched fatty acids and their alkyl esters
GB2152043B (en) Method of preparing fatty acid composition containing high concentration of eicosapentaenoic acid
GB2023636B (en) Process for the production of edible fractions from natural fatty substances and the fractions produced in this way
PH20396A (en) Process for producing fatty acids from lower alcohol ester of fatty acids
IT1099021B (en) PROCESS FOR THE PREPARATION OF NITRILS OF FATTY ACIDS AND GLYCEROL FROM GLYCERIDES, IN PARTICULAR FROM FATS AND NATURAL OILS
DE3460211D1 (en) Process for producing fatty acid esters of ascorbic acid
IT1132230B (en) PROCEDURE FOR THE PRODUCTION OF THE CHOLESTEROL-ESTERASE ENZYME AND FOR HYDROLYSIS OF ESTERS WITH FATTY ACIDS OF CHOLESTEROL BY USING THE ENZYME ITSELF
AT377259B (en) METHOD FOR PRODUCING DIHYDROPYRIDYLIMIDATE ESTERS
ATA82387A (en) METHOD AND DEVICE FOR THE PRODUCTION OF FATTY ACID ESTERS AND THE USE THEREOF
IT1126578B (en) PROCEDURE FOR THE PRODUCTION OF HYDROGENATED FATTY ACIDS
DE3682376D1 (en) METHOD FOR ENRICHING AND SEPARATING UNSATURATED FATTY ACID ESTERS.
DE3677041D1 (en) METHOD FOR PRODUCING SYMMETRIC TRIGLYCERIDES.
PT86163A (en) METHOD FOR THE PRODUCTION OF FATTYAURENITRILES AND GLYCERIN FROM GLYCERIDES
KR900701982A (en) Fatty acid esters, methods for hydrogenation of fats and fatty acids and apparatus for performing the method
IT1104677B (en) PROCEDURE FOR THE PRODUCTION OF MIXED ESTERS OF HYDROXICARBOS SILIC ACIDS AND PARTIAL GLYCERIDES OF FATTY ACIDS
DE69217099T2 (en) Process for the preparation of fatty acid saccharide esters
DE69500995D1 (en) Process for the preparation of fatty acid alkyl glycoside esters
AT382624B (en) METHOD FOR PRODUCING NEW CARBOHYDRATE ESTERS OF ACETYL SALICYL ACID
ATA260682A (en) METHOD FOR THE PRODUCTION OF GLYOXYL ACID AND GLYOXYL ACID ALKYL Ester HALBACETAL
DE3778279D1 (en) METHOD FOR PRODUCING OMEGA HYDROXY FATTY ACIDS.